Literature DB >> 33088351

Recent Survey of Effective Doses of F-18 FDG Torso PET/CT in Korea and the Current Recommendations for CT Protocols of PET/CT.

Ari Chong1, Jung Mi Park2, Kyoungjune Pak3, Yong-Il Kim4, Hyun Woo Kwon5, Eun Seong Lee6, Ki Pyo Nam4, Ho-Young Lee7, Hong Jae Lee8, Ik Dong Yoo9, Jae Seon Eo10, Ji Young Kim11, Joon-Kee Yoon12, Kyeong Min Kim13, Seong Min Kim14, Tae-Sung Kim15.   

Abstract

PURPOSE: This study aimed to construct a database of the effective doses (ED) from F-18 fluorodeoxyglucose (FDG) torso positron emission tomography/computed tomography (PET/CT) in Korea to provide data that supports the reduction of the CT dose of PET/CT and optimization of PET/CT protocols in Korea.
METHODS: We investigated data of ED and CT parameters of FDG PET/CT. The data were analyzed by body weight groups.
RESULTS: A total of 31 hospitals participated in the survey (99 adults). The mean total EDs (± SD) were 8.77 ± 2.76, 10.93 ± 3.14, and 12.57 ± 3.79 mSv for the 55-, 70-, and 85-kg groups, respectively. The FDG EDs were 4.80 ± 0.98, 6.05 ± 1.15, and 6.89 ± 1.52 mSv, and the CT EDs were 4.00 ± 2.12, 4.88 ± 2.51, and 5.68 ± 2.89 mSv, respectively. Of the enrolled hospitals, 54.5% used ultra-low-dose CT protocols, and their CT ED was significantly lower than low-dose CT group in all groups (2.9 ± 1.0, 3.2 ± 1.1, and 3.3 ± 1.0 mSv vs. 6.6 ± 1.6, 7.2 ± 2.1, and 7.9 ± 2.2 mSv, all p < 0.001, respectively). In the ultra-low-dose CT group, the CT ED with the iterative reconstruction was significantly lower than that of CT without iterative reconstruction in the 55-kg group (2.4 ± 0.9 vs. 3.3 ± 0.9, p = 0.04).
CONCLUSIONS: These results and current recommendations can be helpful for optimizing PET/CT diagnostic reference level (DRL) and reducing unnecessary PET/CT radiation exposure. © Korean Society of Nuclear Medicine 2020.

Entities:  

Keywords:  18F-FDG; CT; Effective dose; Guidelines; PET/CT

Year:  2020        PMID: 33088351      PMCID: PMC7560676          DOI: 10.1007/s13139-020-00654-7

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN: 1869-3474


  16 in total

1.  Report to the European Commission: ethical aspects of cloning techniques.

Authors: 
Journal:  Politics Life Sci       Date:  1997-09

2.  The engagement of FDG PET/CT image quality and harmonized quantification: from competitive to complementary.

Authors:  Ronald Boellaard
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-01       Impact factor: 9.236

3.  Radiological protection and safety in medicine. A report of the International Commission on Radiological Protection.

Authors: 
Journal:  Ann ICRP       Date:  1996

Review 4.  Current global and Korean issues in radiation safety of nuclear medicine procedures.

Authors:  H C Song
Journal:  Ann ICRP       Date:  2016-03-09

5.  Multisection CT protocols: sex- and age-specific conversion factors used to determine effective dose from dose-length product.

Authors:  Paul D Deak; Yulia Smal; Willi A Kalender
Journal:  Radiology       Date:  2010-10       Impact factor: 11.105

Review 6.  Optimization of Pediatric PET/CT.

Authors:  Marguerite T Parisi; Mohammed S Bermo; Adam M Alessio; Susan E Sharp; Michael J Gelfand; Barry L Shulkin
Journal:  Semin Nucl Med       Date:  2017-02-16       Impact factor: 4.446

7.  SU-E-I-89: Applying Image Gently and Image Wisely in Nuclear Medicine.

Authors:  M Jafari; A Daus
Journal:  Med Phys       Date:  2012-06       Impact factor: 4.071

8.  Radiation dose to patients from radiopharmaceuticals. Addendum 3 to ICRP Publication 53. ICRP Publication 106. Approved by the Commission in October 2007.

Authors: 
Journal:  Ann ICRP       Date:  2008

9.  Evaluation of patient effective dose in a PET/CT test.

Authors:  Fernanda Guerra Paiva; Priscila do Carmo Santana; Arnaldo Prata Mourão
Journal:  Appl Radiat Isot       Date:  2018-12-20       Impact factor: 1.513

10.  FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0.

Authors:  Ronald Boellaard; Roberto Delgado-Bolton; Wim J G Oyen; Francesco Giammarile; Klaus Tatsch; Wolfgang Eschner; Fred J Verzijlbergen; Sally F Barrington; Lucy C Pike; Wolfgang A Weber; Sigrid Stroobants; Dominique Delbeke; Kevin J Donohoe; Scott Holbrook; Michael M Graham; Giorgio Testanera; Otto S Hoekstra; Josee Zijlstra; Eric Visser; Corneline J Hoekstra; Jan Pruim; Antoon Willemsen; Bertjan Arends; Jörg Kotzerke; Andreas Bockisch; Thomas Beyer; Arturo Chiti; Bernd J Krause
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-12-02       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.